 |
   
|
  |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
International News Health Canada Approves Abbott Diagnostic Instrument, HIV-1 and Hepatitis C TestsJanuary 10, 2007 On Monday, Abbott Laboratories Inc. and Celera Group announced that Health Canada had approved the Abbott m2000, an automated molecular diagnostic instrument, and the Abbott RealTime HIV-1 and hepatitis C viral load tests. The tests were developed for use on the m2000 instrument, which is used to conduct genetic testing in molecular laboratories. Abbott said the m2000 can measure viruses and bacteria in blood or plasma samples in five hours or less. Associated Press 01.08.07  This article was provided by U.S. Centers for Disease Control and Prevention. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update. Visit the CDC's website to find out more about their activities, publications and services.
|
|
Email
Print-Friendly
Glossary
The Body: About The Body | Contact The Body | Content Policy | Content Providers | Advertise With Us | Site Map
Remedy Health Media: About Remedy Health Media | Contact Remedy Health Media | Terms of Use | Privacy Policy
The Body is a service of Remedy Health Media, LLC, 500 5th Avenue, 19th Floor, New York, NY 10110. The Body and its logos are trademarks of Remedy Health Media, LLC, and its subsidiaries, which owns the copyright of The Body's homepage, topic pages, page designs and HTML code. General Disclaimer: The Body is designed for educational purposes only and is not engaged in rendering medical advice or professional services. The information provided through The Body should not be used for diagnosing or treating a health problem or a disease. It is not a substitute for professional care. If you have or suspect you may have a health problem, consult your health care provider.
